Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-02-06 @ 1:46 PM
Study NCT ID:
NCT00060359
Status:
COMPLETED
Last Update Posted:
2015-05-08
First Post:
2003-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Sponsor:
Gynecologic Oncology Group
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Fallopian Tube Carcinoma | View |
| None | Malignant Ovarian Mixed Epithelial Tumor | View |
| None | Ovarian Brenner Tumor | View |
| None | Ovarian Clear Cell Cystadenocarcinoma | View |
| None | Ovarian Endometrioid Adenocarcinoma | View |
| None | Ovarian Mucinous Cystadenocarcinoma | View |
| None | Ovarian Serous Cystadenocarcinoma | View |
| None | Primary Peritoneal Carcinoma | View |
| None | Stage III Ovarian Cancer | View |
| None | Stage IV Ovarian Cancer | View |
| None | Undifferentiated Ovarian Carcinoma | View |
Keywords: